Divi's Laboratories

Last updated

Divi's Laboratories Limited
FormerlyDivi's Research Centre
Company type Public
ISIN INE361B01024
Industry Pharmaceuticals
Founded12 October 1990(34 years ago) (1990-10-12)
HeadquartersDivi Towers, Cyber Hills, Gachibowli,
Hyderabad, Telangana
,
India
Key people
  • Murali Krishna Prasad Divi (MD)
  • Satchandra Kiran Divi (CEO)
Products Active Pharmaceutical Ingredients
Nutraceuticals
ServicesCustom synthesis
RevenueIncrease2.svg₹9,712 crore (US$1.1 billion) (2025)
Increase2.svg₹2,916 crore (US$340 million) (2025)
Increase2.svg₹2,194 crore (US$260 million) (2025)
Total assets Increase2.svg₹16,932 crore (US$2.0 billion) (2025)
Total equity Increase2.svg₹14,969 crore (US$1.8 billion) (2025)
Owner
  • Divi Satchandra Kiran (20.34%)
  • Nilima Motaparti (20.34%)
  • Divi Swarna Latha (5.27%)
  • Divis Biotech Private Limited (3.01%)
  • Murali Krishna Prasad Divi (2.85%)
Number of employees
13,884 (2020)
Subsidiaries
  • Divis Laboratories (USA) Inc
  • Divi’s Laboratories Europe AG
  • Divi’s Nutraceuticals
Website divislabs.com
Footnotes /references
Financials as of 31 March 2025. [1]

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [2] [3] [4] [5] The company manufactures and custom synthesizes generic APIs, intermediates. [6] [7] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. [8] Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. [9]

Contents

History

The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry. [10] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana. [11] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam. [11]

The company went public with its initial public offering (IPO) on 17 February 2003. [12] [10] In 2010, the company established a research centre in Hyderabad. [11]

Facilities

The company has three manufacturing facilities and three R&D centres across India: [11]

Manufacturing

References

  1. ↑ "Statement of Audited Financial Results, Standalone and Consolidated, for the quarter and year ended March 31, 2025" (PDF). Divi's Laboratories Limited. Retrieved 28 May 2025.
  2. ↑ "Company Profile-DIVIS LAB". Dynamic Levels. Archived from the original on 18 October 2020. Retrieved 15 September 2020.
  3. ↑ "Company Profile for Divi's Laboratories Ltd". Reuters. Archived from the original on 18 October 2017. Retrieved 15 September 2020.
  4. ↑ "Divi's Laboratories Ltd Company profile". Bloomberg L.P. Archived from the original on 18 October 2020. Retrieved 15 September 2020.
  5. ↑ "DIVI'S LABORATORIES LIMITED - Company, directors and contact details | Zauba Corp". www.zaubacorp.com. Archived from the original on 18 October 2020. Retrieved 15 September 2020.
  6. ↑ "Top API Manufacturing Company In Hyderabad, India & World | DivisLabs". Divis Laboratories World’s largest API manufacturing facility. Archived from the original on 12 August 2020. Retrieved 15 September 2020.
  7. ↑ Bradstreet, Dun. "Divi's Laboratories company profile". dnb.com. Archived from the original on 18 October 2020.
  8. ↑ Divis Nutraceuticals (14 September 2021). "Press Release: Divi's Nutraceuticals launches CaroNat for natural food and beverage coloration". Divi's Nutraceuticals. Retrieved 27 July 2022.
  9. ↑ "Top Pharmaceuticals & Drugs Stocks in India by Market Capitalisation". www.moneycontrol.com. Archived from the original on 13 January 2023. Retrieved 15 February 2023.
  10. 1 2 "Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB". moneycontrol.com. Archived from the original on 6 June 2020. Retrieved 17 September 2020.
  11. 1 2 3 4 Laboratories, Divi's. "Annual Report" (PDF). divislabs.com. Archived (PDF) from the original on 18 October 2020.
  12. ↑ "Divis Labs Fixes Rs 130 Per Share As Floor Price For IPO". The Financial Express. 11 February 2003. Archived from the original on 17 March 2018. Retrieved 18 September 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.